Work

Figure S4 from AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer

Year: 2026

Type: other

Abstract: Validation of drug screen hits in 2-D and 3-D.

DOI: 10.1158/1535-7163.32710393

Authors: Mannan Nouri, Andreas Varkaris, Maya Ridinger, Susan L. Dalrymple, Christopher M. Dennehy, John T. Isaacs, David J. Einstein, W.N. Brennen, Steven P. Balk

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7164995677

Cites:

Cited by:

Related to: